Clinical Trials · NCT06525675
Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- MedSIR
- Enrollment
- 419
- Start date
- Jul 2022
- Locations
- 36 sites, 6 countries
- Primary endpoint
- Overall Survival (OS)